Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-17

Clinical Trial Update: Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating the safety and efficacy of Clevidipine Butyrate Injection for hypertensive emergencies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clevidipine Butyrate Injection (clevidipine butyrate)

Snippet

Sponsor: Nanjing Yoko Biomedical Co., Ltd. | Conditions: Hypertensive Emergency | Phase 3 | Status: UNKNOWN